1 8 Despite extensive exploration of the diversity of CRISPR (Clustered Regularly Interspaced 1 9 Short Palindromic Repeats) systems, biological applications have been mostly confined to 2 0 Class 2 systems, specifically the Cas9 and Cas12 (formerly Cpf1) single effector proteins. A 2 1 key limitation of exploring and utilizing other CRISPR-Cas systems with unique 2 2 functionalities, particularly Class I types and their multi-protein effector complex, is the 2 3 knowledge of the system's protospacer adjacent motif (PAM) sequence identity. In this work, 2 4 we developed a systematic pipeline, named CASPERpam, that enables us to comprehensively 2 5 assess the PAM sequences of all the available CRISPR-Cas systems in the NCBI database of 2 6 bacterial genomes. The CASPERpam analysis revealed that within the 30,389 assemblies 2 7 previously screen for CRISPR arrays, there exists 26,364 spacers that match somewhere in 2 8 the viral, bacterial, and plasmid databases of NCBI, using the constraints of 95% sequence 2 9
BLASTN search across the viral (13,885 assemblies), plasmid (11,218 assemblies), and 1 0 0 bacterial/prokaryotic (12,9209 assemblies) genome databases of NCBI, using the 95% 1 0 1 sequence identity and 95% coverage constraints to gather only hits with sufficient similarity 1 0 2 (Step 1, Figure 1 ). There were no spacers that generated multiple hits. To identify a PAM 1 0 3 sequence, we collected the hit sequence and included an additional 10 nucleotides on either 1 0 4 side (the "collected" sequence). Because the hit sequence itself may only be a partial match to 1 0 5 the spacer, we extrapolated endpoints of the spacer within the collected sequence. Specifically, the spacer and collected sequences were aligned by finding the largest perfectly 1 0 7 matched sequence shared between the two sequences. Then the indices of the spacer 1 0 8 sequence's start and end within the collected sequence were used to define the locations of 1 0 9 the flanking sequences. From the spacer collection suitable for PAM analysis, we could narrow the number of 1 1 3 assemblies from 30,389 to 6,955 (Step 2, Figure 1 ). Since multiple assemblies can belong to 1 1 4 the same species, we clustered them at the species level to create a total of 1,493 species 1 1 5 (Step 3, Figure 1 ). By choosing species with at least 2 spacer hits, we further reduced the 1 1 6 number of species from 1,493 to 1,049 for which we could search for PAMs (Step 4, Figure   1 1 7 1). In our analysis, strains and substrains were grouped together under a common species.
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While in some rare cases it is possible that PAM sequences might differ between strains and 1 1 9
substrains due to random mutation or perhaps horizontal gene transfer of CRISPR-Cas 1 2 0 machinery among strains [7], we would not have been able to perform further analysis in a 1 2 1 vast majority of species due to the limited number of hits belonging to each substrain. The Cas type was used to determine whether a PAM was located 5' (upstream) or 3' 1 2 5
(downstream) of the hit (Step 5, Figure 1 ). For type I, III (rPAM), IV, and V systems, the that did not appear in the prior classification studies, the genus was used to match the species 1 3 0 to a relative and its Cas type was inferred from the type of its relative. was considered to be the consensus nucleotide. If no nucleotide was higher than 0.5, the 1 3 9 nucleotide(s) that had relative frequency greater than 0.25 were considered to be part of the sequences smaller than 6 were discarded and the remaining were truncated to the length of 1 4 7 the smallest sequence. P. aeruginosa (Figure 2A ), Acinetobacter baumannii ( Figure 2B ), and E. coli ( Figure 2C ). In 1 6 5 addition, we found strong correlation (blue boxes) between the experimental and predicted 1 6 6 PAM sequences of 4 species: S. pyogenes ( Figure 2D ), C. difficile (Figure 2E ), L. bacterium 1 6 7
( Figure 2F ), and B. halodurans ( Figure 2G ). An additional two species had weak correlation 1 6 8 (yellow boxes): S. thermophilus ( Figure 2H ) and T. denticola ( Figure 2I ). Weak correlation with the experimentally derived sequence. Finally, we did not find a match (red boxes) for 1 7 1 the 3 remaining species: N. meningitidis ( Figure 2J ), C. jejuni ( Figure 2K ), and S. aureus
In our analysis, we observed that the complete and strong partial matches appeared in 1 7 4 species that have relatively high spacer hits and consensus Cas-types (Supplementary Table   1 7 5 S1). In contrast, the non-matches correlated to a smaller number of hits. A notable exception 1 7 6
is Bacillus halodurans, which despite a relatively low number of hits returned a strong match 1 7 7
to its experimental PAM. (Table 1) . Interestingly, type II species seem particularly prone to 1 7 8 inaccurate predictions of the PAM sequence, despite large amounts of hits and a consensus 1 7 9
Cas-type in certain scenarios. In contrast to type I systems where the PAM sequence may be 1 8 0 attributed to either the acquisition or interference stage, type II interference mechanisms have
In equation 1, the value h represents the number of hits from all the spacers (Supplementary 1 9 8 Table S1 ). C m and C T refer to the number of detected Cas arrays that match the consensus 1 9 9
type for a designated species and the total number of arrays, respectively [1] . N s =1 for a 2 0 0 species with a well-defined consensus Cas type. However, if a species is not found in the 2 0 1 classification database ( Supplementary Table S2 ), the value of N S is increased by 1 for every 2 0 2 level up in the phylogenetic tree that the species must be traced until matching a relative. The deemed as significant contributors to the PAM sequence (denoted by the subscript "sig"). H avgdev is calculated as follows:
In equation 2, H i,sig is the Shannon entropy of a significant position; H avg represents the 2 0 9
average Shannon entropy across all positions in the flanking sequence; and n sig is the number 10 of significant positions. The f a,i term in equation 3 is the relative frequency of a given 2 1 1 nucleotide "a" at position i.
1 2
We used PamCoS to score all 1049 species in the CASPERpam produced database 2 1 3
( Figure 1 and Supplementary Table S1 ). scores over 400 ( Supplementary Table S1 ) and exhibit the NGG motif as their predicted satisfy this criteria, further sequencing efforts of microbial genomes will aid in providing the 2 2 7 necessary information for accurate in silico PAM prediction.
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To assign a more flexible cutoff for the currently available data and using the 2 2 9
PamCoS scores of species with known PAMs, a score above 10 (0.35 relative PamCoS to P. allow the CASPERpam prediction to be supplemented with only minimal experimentation to 2 4 5 provide confirmation of the predicted sequence. Of the 221 species above the threshold value, 78% had a Class 1 system, an confined to a single Cas type, rather they are spread across systems ( Figure 3A) . One potential explanation is that the PAM motif of Class 1 multi-effector systems is likely subject 2 5 8
to some degree of horizontal gene transfer. Particularly, the Cas8/10 and Cas1/2 proteins, be discounted that this diversity may be underrepresented by the in silico technique, as only other hand, PAM sequences are likely to be mutated for phages to survive, and thus overrepresentation of a random set of mutated sequences despite a close spacer match. Such a hypothesis would result in the in silico process revealing greater non-specificity than would 3 1 1 be shown experimentally. Likely, these two effects are both present, and result in some 3 1 2 overly specific as well as some overly promiscuous sequence predictions from the in silico 3 1 3 method. with novel functionalities, CASPERpam will be a useful bioinformatic tool for those seeking 3 2 6
to understand and harness the diversity of CRISPR systems. 
Results Algorithms
Step 1: Extract spacers
Step 2: Map spacers on to corresponding genomes
Step 3: Identify unique species with mapped spacers
Step 4: Filter species suitable for analysis and identify PAM sequences
Step 5: Perform PAM analysis and assess confidence 
Pseudomonas aeruginosa
Class 1 type I-F Exp. PAM: CC
Escherichia coli
Class 1 Type I-E Exp. PAM: AWG
Acinetobacter baumannii
Class 1 Type I-F Exp. PAM: CC
Neisseria meningitidis
Class 2 Type II-C Exp. PAM: NNNGATT
Streptococcus pyogenes
Class 2 Type II-A Exp. PAM: NGG
Streptococcus thermophilus
Class 2 Type II-A Exp. PAM: NNNNGWWT
Bacillus halodurans
Class 1 Type I-C Exp. PAM: YYC
Campylobacter jejuni
Class 2 Type II-C Exp. PAM: NNNNRYAC
Staphyloccocus aureus
Class 2, Class 1 Type II-A, Type III-A Exp. PAM: NNGRRT (3')
Lachnospirae bacterium
Class 2 
